Investment Associate at Asset Management Firm Positioned in $SPY $QQQ Market believer 📊 Early mornings 🌅 Clean lifestyle 🥗

Toronto, CA
Joined July 2013
Clean 14% in 5 days, that Malaysia catalyst plus Cogni AI angle is doing work. Watching this one. #teenageee $WMT $PLTR
Put $30K into $RYET and caught roughly a 14% move over the past 5 days That’s about $4,200 in gains on paper. The Malaysia healthcare catalyst, Cogni AI story and improving momentum all helped keep this one on my radar $GOOGL $PLTR $NFLX $AVGO
1
Amb Perdue insists that in meetings with Xi, Trump has been "strong" on Taiwan and told Xi the US supports the 3 Communiques and 6 assurances. However, he adds the leaders talk about US arms sales to Taiwan "every time they meet." He also says the US doesn't support Taiwan independence and doesn't support coercion. Shouldn't the US oppose coercion? Full interview: foxnews.com/video/6405700393…
19
26
126
14,356
RYET is trying to take Cogni AI into more than one vertical. Malaysia adds another international market to the company's expansion map. The Malaysia angle is worth following. $MU #Tejran #bb28
The bigger picture behind the latest $RYET news is much larger than one Malaysia agreement AI in healthcare is becoming a global industry. Current market estimates put the sector at roughly $56B in 2026, with forecasts reaching around $1 TRILLION by 2034. That is the market backdrop for RYET latest move. Ruanyun announced a definitive agreement involving Cogni AI and BioNexus Gene Lab in Malaysia, giving its AI technology a path into healthcare rather than keeping it limited to education and enterprise applications. The structure is interesting too: an exclusive license framework of up to 20 years, 10% royalty economics on qualifying technology receipts, and 560K BGLC shares at closing. For me, this is what makes the news important. RYET is not suddenly becoming a healthcare giant. It is testing whether Cogni AI can be licensed into a completely different industry and international market while that industry itself is experiencing massive AI adoption. Education was the starting point. Enterprise AI expanded the story. Now healthcare adds another potential use case. If Cogni AI can continue moving across industries and markets, that becomes a much more interesting business model than relying on one product or one sector. Malaysia may be only the first healthcare test, but it puts RYET directly in front of one of the fastest-growing global technology trends.
4
10% royalty on a 20-year exclusive is the kind of economics that actually moves the needle. This one's got legs. #Tejran $GOOGL $RIVN
Fresh catalyst for $RYET The Malaysia healthcare deal with BioNexus gives Cogni AI a new commercial path, with up to 20 years of exclusivity, 10% royalty economics and 560K BGLC shares at closing $AVGO $MU
2
20-year license with 10% royalty is real recurring revenue. This one's just getting warm. 👀 #teenageee $SOUN $ADBE
$RYET trading around $0.88, up +2.31% today as the market reacts to the fresh Malaysia healthcare expansion The new BioNexus/Cogni AI deal adds a 20-year license framework, 10% royalty economics and 560K BGLC shares at closing. Fresh catalyst. Fresh attention
3
Healthcare plus AI with 20-year licensing? That's real recurring revenue potential. Watching $RYET closely here. #bb28 $BA $ASTS
$RYET adds healthcare to its expansion story Its new Malaysia agreement with BioNexus Gene Lab brings Cogni AI into healthcare, with a license of up to 20 years, 10% royalty economics and 560K BGLC shares at closing. New market. New vertical. Bigger global footprint $SPY $QQQ
3
$RYET volume doesn't lie, and that revenue update gives it real legs. $VEEA premarket action worth a look too. Watching both for continuation. #finance $PTC $MU
Two names are lighting up the morning watchlist $RYET stays on high alert after last week’s volume surge and the $9.3M-$9.5M H1 FY2027 revenue update Meanwhile $VEEA is showing strong premarket momentum Different setups, same theme: traders are watching for continuation
1
The next move often starts with a headline. Get fresh market context without spending all day scrolling at dailymarketmemo.com/email $F $AVGO #DailyMarketMemo Market watch 200
27
Finally a space that values signal over noise. This is how it should be done. #teenageee $TEM $MRNA
Catch the signal. Skip the noise. Join a focused market community where traders discuss fresh news, unusual activity, catalysts and setups across stocks and tech Research first. No guaranteed calls. No hype promises Join the Discord community:stock-alerts-hunters.workw37…
174
$RYET went from $0.37M to $9.3M-$9.5M in six months. That H1 FY2027 print already beats the entire $7.48M FY2026 year 🔥 #BBNaija $NU $LOW
This is the $RYET update I wanted to highlight again Preliminary H1 FY2027 revenue is expected at $9.3M-$9.5M, versus only about $0.37M in H1 FY2026 And that six-month figure already exceeds the company’s $7.48M FY2026 full-year revenue That is a major change in operating scale Preliminary and unaudited, but the revenue growth is now the main story to watch nitter.cf/TradePulse2/status/210…
271
$700 Billion added to the US stock market on the news that more people are losing jobs.
170
325
89
6,078
255,257
$RYET H1 FY2027 prelim revenue $9.3M-$9.5M vs $0.37M in H1 FY2026 — that's not growth, that's a different company. #jonita $JOBY $NU
The biggest number in the $RYET story today is $9.3M-$9.5M That is expected preliminary H1 FY2027 revenue, compared with only about $0.37M in H1 FY2026 The business is operating at a completely different scale now $OPEN $QQQ
139
$RYET doing $9.3M-$9.5M in H1 FY2027 when full-year FY2026 was just $7.48M. One half-year topping an entire prior year. Smart Campus alone at $5.0M-$5.2M. #BBNaija $GME $META
One number stands out on $RYET: $9.3M-$9.5M That’s expected H1 FY2027 revenue, versus about $0.37M in H1 FY2026 A huge jump in operating scale, with Smart Campus expected at $5.0M-$5.2M
5
352
$RYET H1 FY2027 preliminary revenue $9.3M-$9.5M vs just $0.37M in H1 FY2026 — that's already above the $7.48M full-year FY2026. Smart Campus alone $5.0M-$5.2M. #Tejran $VKTX $NIO
$RYET is starting to look like a real commercialization story YeeZo moved from announcement to delivery and customer acceptance Campus services became a major revenue engine AI applications are now expected to contribute measurable revenue The next step is obvious: stack more paid deployments on top of this base
221
$RYET $9.3M-$9.5M in H1 FY2027 vs $7.48M for the entire FY2026? Half a year beating a full year is wild 🔥 #jonita $ORCL $MCD
$RYET quietly delivered one of the more aggressive revenue inflections in its recent history ~$0.37M H1 revenue a year ago $9.3M-$9.5M expected this H1 Yes, the comparison base was tiny But the new absolute revenue level is what matters now — and it’s materially bigger
105
The h1 fy2027 outlook points to a major jump in operating scale. This is a much more meaningful update than a generic AI headline. a major revenue step-up is showing up at ryet $RYET
8
Chairman @SECPaulSAtkins on Making IPOs Great Again: “We have had 583 companies go public in the last year and a half." "That’s up 75% from the previous year and a half of the last part of the Biden administration . . . I want to keep our public markets strong."
69
34
5
167
34,737
An $880K contract against $7.48M FY revenue is real commercial traction, not hype. $RYET AI labs going live is the kind of execution small caps need. #BBNaija $AMC $IBM
$880,000 AI CONTRACT $RYET YeeZo deployment covers 10 AIGC labs + 610 workstations. For context, RYET reported $7.48M FY2026 revenue - meaning this single contract is roughly 12% of last year’s revenue. That’s a number traders can understand fast
251
Qullamaggie posting has become a cottage industry.
When are yall going to stop tagging @Qullamaggie in every other post to engagement farm?
3
1
44
12,005